InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Reaches Agreement with ATERA SAS to Aid INM-750 Research in Pre-Clinical Tests
InMed to test INM-750 in vitro, estimates clinical trials for 2018-2020 ATERA SAS to develop 3D skin models to help…
InMed to test INM-750 in vitro, estimates clinical trials for 2018-2020 ATERA SAS to develop 3D skin models to help…
In an interview with Stock Day, CEO Chris Bunka of Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) discussed the company’s…
Multi-billion industry growing at a compound annual growth rate of 31% Unique business plan providing ground-floor investment opportunities Existing portfolio…
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it has finalized and fully executed a licensing…
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of its cryptocurrency education and trading subscription service…
Leading-edge provider of prepaid card programs and processing services Portfolio includes millions of prepaid debit cards Company serves some of…
Proposed legislation would remove cannabis from the list of Schedule I controlled substances. If successful, it would pave the way…
Global Payout, Inc. (OTC: GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international…
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds,…
Incubator for developers of mobile apps Digital game industry continues to grow Mobile app development across Apple, RIM, Google and…